UOC
BRLI

UBS O'Connor’s BIO-REFERENCE LABS INC-NEW- BRLI Stock Holding History

UBS O'Connor’s Portfolio BRLI Stock Details BRLI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-16,143
Closed -$569K – 1035
2015
Q1 		$569K Buy
16,143
+8,260
+105% +$279K 0.01% 645
2014
Q4 		$253K Buy
+7,883
New +$228K ﹤0.01% 576

Other funds holding BRLI

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BTW
Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $16.4B AUM 55.44% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.6B AUM 93.19% 1-Year Est. Return

UBS O'Connor's BRLI Position: Q2 2015 in Review

UBS O'Connor sold out of BIO-REFERENCE LABS INC-NEW- (BRLI) in Q2 2015, closing a stake of 16,143 shares — an estimated $569K sold.

UBS O'Connor first reported a position in BRLI in Q4 2014 and held it in 2 quarters. The position peaked at $569K in Q1 2015. 183 funds tracked by Wall St. Rank hold BRLI as of Q2 2015.

  • UBS O'Connor reported no remaining BIO-REFERENCE LABS INC-NEW- position as of Q2 2015 after selling out during the quarter.
  • UBS O'Connor sold 16,143 BIO-REFERENCE LABS INC-NEW- shares in Q2 2015, an estimated $569K.
  • UBS O'Connor first reported a position in BIO-REFERENCE LABS INC-NEW- in Q4 2014 and held it in 2 quarters.
  • UBS O'Connor's BIO-REFERENCE LABS INC-NEW- position peaked at $569K in Q1 2015.
  • 183 funds tracked by Wall St. Rank held BIO-REFERENCE LABS INC-NEW- as of Q2 2015.

Based on UBS O'Connor's 13F filing for Q2 2015, filed 13 Aug 2015.